RCM

RA Capital Management Portfolio holdings

AUM $5.94B
1-Year Return 18.15%
This Quarter Return
+33.62%
1 Year Return
+18.15%
3 Year Return
+417.5%
5 Year Return
+458.13%
10 Year Return
+21,247.51%
AUM
$1.2B
AUM Growth
+$88.2M
Cap. Flow
+$15.4M
Cap. Flow %
1.29%
Top 10 Hldgs %
81.29%
Holding
35
New
8
Increased
4
Reduced
6
Closed
8

Top Buys

1
SAGE
Sage Therapeutics
SAGE
$75M
2
IFRX icon
InflaRx
IFRX
$60.3M
3
SCPH icon
scPharmaceuticals
SCPH
$34.5M
4
DRNA
Dicerna Pharmaceuticals, Inc.
DRNA
$22.9M
5
APLS icon
Apellis Pharmaceuticals
APLS
$19.5M

Top Sells

1
RXDX
Ignyta, Inc.
RXDX
$50.7M
2
GTHX
G1 Therapeutics, Inc. Common Stock
GTHX
$50.1M
3
ACHN
Achillion Pharmaceuticals, Inc.
ACHN
$37.6M
4
INSM icon
Insmed
INSM
$22.6M
5
ACOR
Acorda Therapeutics, Inc.
ACOR
$21.3M

Sector Composition

1 Healthcare 96.25%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
CHMA
26
DELISTED
Chiasma, Inc. Common Stock
CHMA
$2M 0.17%
1,176,806
-219,594
-16% -$373K
ACHN
27
DELISTED
Achillion Pharmaceuticals, Inc.
ACHN
$1.69M 0.14%
585,890
-13,047,330
-96% -$37.6M
INSM icon
28
Insmed
INSM
$30.1B
– –
-722,714
Closed -$22.6M
SGMO icon
29
Sangamo Therapeutics
SGMO
$160M
– –
-1,250,000
Closed -$18.8M
TGTX icon
30
TG Therapeutics
TGTX
$5.06B
– –
-700,000
Closed -$8.3M
VNDA icon
31
Vanda Pharmaceuticals
VNDA
$274M
– –
-243,971
Closed -$4.37M
ACOR
32
DELISTED
Acorda Therapeutics, Inc.
ACOR
– –
-7,502
Closed -$21.3M
IMMU
33
DELISTED
Immunomedics Inc
IMMU
– –
-1,478,742
Closed -$20.7M
RXDX
34
DELISTED
Ignyta, Inc.
RXDX
– –
-4,106,601
Closed -$50.7M
1
2